Informative Exhibition for Deprescribing Benzodiazepines
NCT06467019 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 6410
Last updated 2025-06-26
Summary
The goal of this trial is to determine if an interactive and informative exhibition in the waiting room of a Primary Care Clinic can reduce the use of benzodiazepines in adults. The main question it aims to answer is:
• Does an interactive and informative exhibition reduce the number of participants using benzodiazepines? Researchers will compare benzodiazepine consumption before and after the interactive and informative exhibition implementation at study center.
Participants will receive an informative and interactive exhibition on the risks of chronic benzodiazepine use. A single informative session on the same topic will be conducted for health professionals.
Conditions
- Benzodiazepine-Related Disorders
Interventions
- OTHER
-
Informative Session
The intervention consists of implementing an interactive exhibition on the risks of chronic benzodiazepine treatment in the waiting room of a primary care center. Additionally, the health professionals at the center will receive a single informative session on the same topic.
Sponsors & Collaborators
-
Consorci Sanitari de l'Alt Penedès i Garraf
lead OTHER
Principal Investigators
-
Jordi Milozzi, MD · Centro de Salud Vilanova i la Geltrú 3 Baix A Mar-CSAPG
Eligibility
- Min Age
- 18 Years
- Max Age
- 99 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2024-06-13
- Primary Completion
- 2026-07-31
- Completion
- 2026-07-31
Countries
- Spain
Study Locations
More Related Trials
-
Effects of Ondansetron in Obsessive-compulsive and Tic Disorders
NCT03239210 ·Status: COMPLETED ·Phase: PHASE4
-
Psychological Mobile Interventions to Reduce Distress
NCT05294809 ·Status: COMPLETED ·Phase: NA
-
Predicting Medication Response in Obsessive Compulsive Disorder
NCT01404871 ·Status: COMPLETED ·Phase: NA
-
Long-term Safety Study of Adjunctive Troriluzole in Subjects With Obsessive Compulsive Disorder
NCT04708834 ·Status: TERMINATED ·Phase: PHASE3
-
Application of Vagal Stimulation in Exposure and Response Prevention for Obsessive Compulsive Disorder
NCT02196090 ·Status: UNKNOWN ·Phase: NA
-
Piloting MOL Intervention for Neuroleptic Decision Making
NCT03537040 ·Status: COMPLETED ·Phase: NA
-
Electrical Vestibular Stimulation (VeNS), Compared to a Sham Control For The Management Of Anxiety
NCT05907967 ·Status: COMPLETED ·Phase: NA
-
Mobile App for Obsessive-compulsive Disorder in Adolescents
NCT06033391 ·Status: COMPLETED ·Phase: NA
-
Brief Cognitive Behavioral Therapy to Enhance Benzodiazepine Deprescribing
NCT06119308 ·Status: COMPLETED ·Phase: NA
-
Anxiety in Older Veterans
NCT02400723 ·Status: COMPLETED ·Phase: NA
-
Psychosocial and Medication Treatment for Anxiety in Alcoholism
NCT00248612 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Duloxetine vs Placebo in the Treatment of General Anxiety
NCT00475969 ·Status: COMPLETED ·Phase: PHASE3
-
Influence of Pregnenolone on Exposure Therapy in Obsessive-compulsive Disorder
NCT01949753 ·Status: UNKNOWN ·Phase: PHASE2
-
Virtual Reality System for Anxiety and OCD
NCT03636022 ·Status: COMPLETED ·Phase: NA
-
Trial of Low-Dose Xenon For The Treatment Of Obsessive-Compulsive Disorder
NCT02098148 ·Status: WITHDRAWN ·Phase: PHASE2
-
A Study to Evaluate the Efficacy and Safety of Adjunctive Troriluzole in Obsessive-Compulsive Disorder
NCT04693351 ·Status: COMPLETED ·Phase: PHASE3
-
A Lifestyle Intervention to Reduce Cardiometabolic Risk Factors in Individuals With Obsessive-compulsive Disorder
NCT07206212 ·Status: RECRUITING ·Phase: NA
-
Predicting Treatment Response to Exposure Therapy Using Carbon Dioxide
NCT03925987 ·Status: COMPLETED ·Phase: NA
-
Evaluation of the Effects of Etifoxine 100 mg and Lorazepam 2 mg on Vigilance and Cognitive Functions in the Elderly
NCT02147548 ·Status: COMPLETED ·Phase: PHASE3
-
A Study To Compare Emotional Changes In Subjects With Social Anxiety Disorder
NCT00470483 ·Status: COMPLETED ·Phase: PHASE1
-
Comparing Exposure v Imagery Rescripting in People With OCD: a SCED
NCT06944366 ·Status: RECRUITING ·Phase: NA
-
Processes and Circuitry Underlying Threat Sensitivity as a Treatment Target for Co-morbid Anxiety and Depression
NCT06004115 ·Status: RECRUITING ·Phase: PHASE4
-
Evaluating Unilateral Deep Brain Stimulation in Patients With Obsessive Compulsive Disorder
NCT03894397 ·Status: COMPLETED ·Phase: NA
-
Troriluzole (BHV-4157) in Adult Participants With Obsessive Compulsive Disorder
NCT03299166 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
EDG004 Treatment of Adult Patients With Generalized Anxiety Disorder (GAD)
NCT02305797 ·Status: COMPLETED ·Phase: PHASE3